CY1118166T1 - Μοδαφινιλη για τη χρηση της στην αγωγη κοκαϊνομανων - Google Patents
Μοδαφινιλη για τη χρηση της στην αγωγη κοκαϊνομανωνInfo
- Publication number
- CY1118166T1 CY1118166T1 CY20161101079T CY161101079T CY1118166T1 CY 1118166 T1 CY1118166 T1 CY 1118166T1 CY 20161101079 T CY20161101079 T CY 20161101079T CY 161101079 T CY161101079 T CY 161101079T CY 1118166 T1 CY1118166 T1 CY 1118166T1
- Authority
- CY
- Cyprus
- Prior art keywords
- modafinil
- less
- hours
- pharmaceutical composition
- modafinili
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Addiction (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Η παρούσα εφεύρεση αφορά τη χρήση μοδαφινίλης για τον εθισμό εις την κοκαΐνη. Η μοδαφινίλη η οποία χρησιμοποιείται είναι το δεξιόστροφο εναντιομερές αυτής (μοδαφινίλη S), η οποία παρουσιάζει έναν πολύ ταχύ χρόνο αποδέσμευσης, λιγότερο από 1 ώρα, κατά προτίμηση μεταξύ 15 και 30 λεπτών, και ένα πολύ μειωμένο αποτέλεσμα εγρήγορσης, μικρότερο από 4 ώρες και κατά προτίμηση μικρότερο από 2 ώρες. Απορροφάται υπό τη μορφή μίας φαρμακευτικής σύνθεσης μέσω χορήγησης από του στόματος, όπου κάθε μοναδιαία δόση περιλαμβάνει 25 έως 200 mg, κατά προτίμηση 50 έως 100 mg μοδαφινίλης S. Χρήση αυτής της φαρμακευτικής σύνθεσης ως αγωγή χορήγησης υποκατάστατου για κοκαϊνομανείς.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1200581A FR2987267B1 (fr) | 2012-02-28 | 2012-02-28 | Application du modafinil dans le traitement de substitution des cacainomanes |
| PCT/FR2013/000052 WO2013128088A1 (fr) | 2012-02-28 | 2013-02-25 | Application du modafinil dans le traitement des cocaïnomanes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1118166T1 true CY1118166T1 (el) | 2017-06-28 |
Family
ID=48083447
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20161101079T CY1118166T1 (el) | 2012-02-28 | 2016-10-26 | Μοδαφινιλη για τη χρηση της στην αγωγη κοκαϊνομανων |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US20150073055A1 (el) |
| EP (1) | EP2819655B1 (el) |
| JP (1) | JP6163169B2 (el) |
| KR (1) | KR101897855B1 (el) |
| CN (1) | CN104159575B (el) |
| AR (1) | AR090169A1 (el) |
| AU (1) | AU2013224831B2 (el) |
| BR (1) | BR112014020626A2 (el) |
| CA (1) | CA2863159C (el) |
| CL (1) | CL2014002203A1 (el) |
| CY (1) | CY1118166T1 (el) |
| DK (1) | DK2819655T3 (el) |
| EA (1) | EA025692B1 (el) |
| ES (1) | ES2593276T3 (el) |
| FR (1) | FR2987267B1 (el) |
| HR (1) | HRP20161165T1 (el) |
| HU (1) | HUE030737T2 (el) |
| IL (1) | IL234009B (el) |
| IN (1) | IN2014DN07831A (el) |
| LT (1) | LT2819655T (el) |
| MX (1) | MX348222B (el) |
| NZ (1) | NZ628009A (el) |
| PH (1) | PH12014501837A1 (el) |
| PL (1) | PL2819655T3 (el) |
| PT (1) | PT2819655T (el) |
| RS (1) | RS55238B1 (el) |
| SG (1) | SG11201405316WA (el) |
| SI (1) | SI2819655T1 (el) |
| SM (1) | SMT201600363B (el) |
| TW (1) | TWI626042B (el) |
| UA (1) | UA113301C2 (el) |
| WO (1) | WO2013128088A1 (el) |
| ZA (1) | ZA201405910B (el) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105055404B (zh) * | 2015-08-19 | 2017-07-18 | 四川大学 | Hmgcs2抑制剂在制备治疗可卡因成瘾的药物中的用途 |
| CN105055412B (zh) * | 2015-08-20 | 2018-06-19 | 四川大学 | Nampt抑制剂在制备治疗可卡因成瘾的药物中的用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5618845A (en) * | 1994-10-06 | 1997-04-08 | Cephalon, Inc. | Acetamide derivative having defined particle size |
| FR2771004B1 (fr) | 1997-11-19 | 2000-02-18 | Inst Curie | Utilisation de derives de benzhydryl sulfinyle pour la fabrication de medicaments ayant un effet eveillant dans des situations de troubles de la vigilance d'origine medicamenteuse |
| US20010034373A1 (en) | 2000-02-09 | 2001-10-25 | Matthew Miller | Low dose modafinil for enhancement of cognitive function |
| WO2002030414A1 (en) * | 2000-10-11 | 2002-04-18 | Cephalon, Inc. | Compositions comprising modafinil compounds |
| US20040006532A1 (en) | 2001-03-20 | 2004-01-08 | David Lawrence | Network access risk management |
| US20060024370A1 (en) * | 2004-07-29 | 2006-02-02 | Cephalon France | Modafinil oral lyophilizate |
| US7093476B2 (en) | 2004-09-15 | 2006-08-22 | Ut-Battelle, Llc | Method for fabricating thin californium-containing radioactive source wires |
| CA2614777C (en) * | 2005-07-21 | 2012-04-17 | Neurohealing Pharmaceuticals, Inc. | Rapid onset and short term modafinil compositions and methods of use thereof |
| EP2043623A4 (en) * | 2006-07-12 | 2013-03-20 | Elan Pharma Int Ltd | NANOPARTICLE FORMULATIONS OF MODAFINIL |
| EP1980240A1 (en) * | 2007-04-11 | 2008-10-15 | Cephalon France | Lyophilized pharmaceutical compositions and methods of making and using same |
| US8173169B2 (en) * | 2007-07-11 | 2012-05-08 | Hikma Pharmaceuticals | Formulation and process for the preparation of modafinil |
-
2012
- 2012-02-28 FR FR1200581A patent/FR2987267B1/fr not_active Expired - Fee Related
-
2013
- 2013-02-25 SI SI201330319A patent/SI2819655T1/sl unknown
- 2013-02-25 MX MX2014010237A patent/MX348222B/es active IP Right Grant
- 2013-02-25 EA EA201400960A patent/EA025692B1/ru not_active IP Right Cessation
- 2013-02-25 SG SG11201405316WA patent/SG11201405316WA/en unknown
- 2013-02-25 DK DK13715263.3T patent/DK2819655T3/en active
- 2013-02-25 HU HUE13715263A patent/HUE030737T2/en unknown
- 2013-02-25 US US14/381,896 patent/US20150073055A1/en not_active Abandoned
- 2013-02-25 CA CA2863159A patent/CA2863159C/fr not_active Expired - Fee Related
- 2013-02-25 IN IN7831DEN2014 patent/IN2014DN07831A/en unknown
- 2013-02-25 UA UAA201409664A patent/UA113301C2/uk unknown
- 2013-02-25 RS RS20160882A patent/RS55238B1/sr unknown
- 2013-02-25 AU AU2013224831A patent/AU2013224831B2/en not_active Ceased
- 2013-02-25 NZ NZ628009A patent/NZ628009A/en not_active IP Right Cessation
- 2013-02-25 KR KR1020147023180A patent/KR101897855B1/ko active IP Right Grant
- 2013-02-25 BR BR112014020626A patent/BR112014020626A2/pt not_active Application Discontinuation
- 2013-02-25 ES ES13715263.3T patent/ES2593276T3/es active Active
- 2013-02-25 LT LTEP13715263.3T patent/LT2819655T/lt unknown
- 2013-02-25 JP JP2014559270A patent/JP6163169B2/ja not_active Expired - Fee Related
- 2013-02-25 EP EP13715263.3A patent/EP2819655B1/fr active Active
- 2013-02-25 PT PT137152633T patent/PT2819655T/pt unknown
- 2013-02-25 WO PCT/FR2013/000052 patent/WO2013128088A1/fr active Application Filing
- 2013-02-25 CN CN201380011342.7A patent/CN104159575B/zh not_active Expired - Fee Related
- 2013-02-25 PL PL13715263T patent/PL2819655T3/pl unknown
- 2013-02-27 AR ARP130100596A patent/AR090169A1/es unknown
- 2013-02-27 TW TW102106817A patent/TWI626042B/zh not_active IP Right Cessation
-
2014
- 2014-08-07 IL IL234009A patent/IL234009B/en active IP Right Grant
- 2014-08-12 ZA ZA2014/05910A patent/ZA201405910B/en unknown
- 2014-08-14 PH PH12014501837A patent/PH12014501837A1/en unknown
- 2014-08-19 CL CL2014002203A patent/CL2014002203A1/es unknown
-
2016
- 2016-09-12 HR HRP20161165TT patent/HRP20161165T1/hr unknown
- 2016-10-12 SM SM201600363T patent/SMT201600363B/it unknown
- 2016-10-26 CY CY20161101079T patent/CY1118166T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1118813T1 (el) | Φαρμακευτικες συνθεσεις συν-κρυσταλλων τραμαδολης και κοξιμπων | |
| CY1121150T1 (el) | Νευροδραστικα 19-αλκοξυ-17-υποκατεστημενα στεροειδη, χρησιμα σε μεθοδους θεραπειας | |
| CY1122648T1 (el) | Διαδικασια για την παρασκευη συνθεσεων που περιεχουν υαλουρονικο οξυ και υδροχλωρικη μεπιβακαϊνη | |
| WO2015095811A3 (en) | Combination therapy with neoantigen vaccine | |
| EA201490748A1 (ru) | Лечение рассеянного склероза комбинацией лахинимода и финголимода | |
| UA109991C2 (xx) | Карбаматні сполуки, їх отримання і застосування | |
| CL2013000063A1 (es) | Un método para tratar a un sujeto que comprende administrar n-etil-n-fenil1,2-dihidroxi-4-hodroxi-5-cloro-1-metil-2-oxoquinolina-3-carboxamida opcionalmente deuterada, para el tratamiento de una enfermedad autoinmunitaria; una mezcla de los mismos; composición farmaceutica y su proceso de preparacion. | |
| CL2012002424A1 (es) | Método para tratar artitris reumatoide que comprende administrar al paciente laquinimod y metotrexato por vía oral; composición farmacéutica que los comprende. | |
| GT201300254A (es) | Triazolopiridinas | |
| CY1115081T1 (el) | Νεο εκχυλισμα απο γαϊδουραγκαθο, μεθοδος για την παρασκευη και η χρηση του | |
| BR112012003280A2 (pt) | composição farmacêutica para administração oral, método para tratar uma doença, uso do composto, e, composto. | |
| MX347105B (es) | Composiciones farmaceuticas que comprenden hidromorfona y naloxona. | |
| CL2014003607A1 (es) | Compuestos derivados de benzodioxol, inhibidores de la acetilcolinesterasa; metodo de preparacion; compuestos intermediarios; composicion farmaceutica; y uso en la prevencion o el tratamiento de la enfermedad de alzheimer. | |
| FI20115165A0 (fi) | Terapeuttisia ja diagnostisia menetelmiä | |
| UA113975C2 (xx) | Застосування фармацевтичної композиції або добавки, яка містить фосфатидилсерин і куркумін (варіанти) | |
| CY1118166T1 (el) | Μοδαφινιλη για τη χρηση της στην αγωγη κοκαϊνομανων | |
| ECSP16005208A (es) | Composición farmacéutica anti-tuberculosis estable en una forma de un comprimido recubierto que comprende gránulos de isoniazid y gránulos de rifapentina y su proceso de preparación | |
| BR112012028906A2 (pt) | polimorfos de benzoato de alogliptina | |
| CO7170180A2 (es) | Composición farmacéutica inyectable de dexketoprofeno y tramadol | |
| BR112014014289A8 (pt) | método de tratamento de diabetes, formulação para administração oral, composição, e, uso de qualquer um ou mais dos compostos fenoxipirimidinona e insulina | |
| ES2422563A1 (es) | Composición farmacéutica inyectable de ibuprofeno y arginina, su procedimiento de preparación, forma de dosificación unitaria y utilización de la misma | |
| UY35748A (es) | Terapia combinada con laquinimod para el tratamiento de la esclerosis múltiple | |
| EA201200799A1 (ru) | Гепатопротекторное средство | |
| BR112017003425A2 (pt) | composição farmacêutica para o tratamento de dor dentária ou mandibular aguda | |
| WO2014172453A3 (en) | Novel compositions useful in treating brain-related diseases or disorders and methods using same |